Lysteda (Ferring Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Lysteda drug offered from Ferring Pharmaceuticals Inc.. This Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Ferring Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Tranexamic Acid |
| SUBSTANCE NAME: | TRANEXAMIC ACID |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-05-17 |
| END MARKETING DATE: | 0000-00-00 |
Lysteda HUMAN PRESCRIPTION DRUG Details:
| Item Description | Lysteda from Ferring Pharmaceuticals Inc. |
| LABELER NAME: | Ferring Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 650(mg/1) |
| START MARKETING DATE: | 2010-05-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55566-2110_fa9c91fd-c59a-479a-8107-e26cdba94075 |
| PRODUCT NDC: | 55566-2110 |
| APPLICATION NUMBER: | NDA022430 |
Other TRANEXAMIC ACID Pharmaceutical Manufacturers / Labelers:
